Versus

In August 2026, Versus concentrated 33.11% of sales in Flower with year-over-year decline of 59.22% and month-over-month decline of 18.83%, while Vapor Pens held 24.53% share with declines of 43.61% YoY and 8.09% MoM. Pre-Roll represented 20.10% share with a 9.66% YoY decline and a 15.50% MoM decline, and Beverage accounted for 16.57% share with a 9.17% YoY decline and an 8.86% MoM decline. Secondary categories were comparatively stable on a monthly basis, with Concentrates at 5.68% share and just a 0.85% MoM dip despite a 13.21% YoY decline, whereas Edible fell to 0.01% share with a 93.06% YoY slide and 35.17% MoM drop. The pattern implies a portfolio still anchored in Flower and Vapor Pens but with quicker MoM pressure in Flower and Pre-Roll, suggesting short-term rebalancing potential toward categories with shallower MoM erosion like Concentrates and Beverage.

These shifts indicate that Versus’s positioning is exposed where average prices are higher and YoY contraction is steep, as seen in Flower at an average price of $53.60 alongside a 59.22% YoY decline and rank pressure evidenced by rank 11 in Flower in Saskatchewan. With brand-level sales down 41.82% YoY and average price down 23.26% YoY to $18.30, the relative resilience in Beverage (9.17% YoY decline, 8.86% MoM decline) and the flat MoM profile of Concentrates (0.85% MoM decline, 13.21% YoY decline) point to a need to emphasize value-led, lower-ticket formats where share can be defended, while Flower’s 18.83% MoM contraction and Pre-Roll’s 15.50% MoM contraction imply tightening assortment and price-pack architecture to preserve the 33.11% and 20.10% shares without further rank slippage.